{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:01:28Z","timestamp":1770447688270,"version":"3.49.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["VIH\/SAU\/0021\/2011"],"award-info":[{"award-number":["VIH\/SAU\/0021\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["SFRH\/BD\/87016\/2012"],"award-info":[{"award-number":["SFRH\/BD\/87016\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["SFRH\/BD\/96519\/2013"],"award-info":[{"award-number":["SFRH\/BD\/96519\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["SFRH\/BPD\/92934\/2013"],"award-info":[{"award-number":["SFRH\/BPD\/92934\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"FEDER","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"name":"POCI","award":["POCI-01-0145-FEDER-007274"],"award-info":[{"award-number":["POCI-01-0145-FEDER-007274"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.actbio.2016.08.018","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T17:30:40Z","timestamp":1471714240000},"page":"332-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system"],"prefix":"10.1016","volume":"44","author":[{"given":"Alexandra","family":"Machado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6886-3900","authenticated-orcid":false,"given":"Cassilda","family":"Cunha-Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rute","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edtor","family":"Seabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domingos","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2317-2759","authenticated-orcid":false,"given":"Jos\u00e9","family":"das Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2016.08.018_b0005","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.actbio.2016.08.018_b0010","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJMoa1410649","article-title":"Tenofovir gel for the prevention of herpes simplex virus type 2 infection","volume":"373","author":"Abdool Karim","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2016.08.018_b0015","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention in women","author":"Baeten","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2016.08.018_b0020","unstructured":"A. Nel, S. Kapiga, L.-G. Bekker, B. Devlin, M. Borremans, Z. Rosenberg, Safety and efficacy of dapivirine vaginal ring for HIV-1 prevention in african women, in: CROI \u2013 Conference on Retrovirus and Opportunistic Infections, Boston, MA, USA, 2016."},{"key":"10.1016\/j.actbio.2016.08.018_b0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"Marrazzo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2016.08.018_b0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/infdis\/jiv333","article-title":"Pharmacological measures of treatment adherence and risk of HIV infection in the VOICE study","volume":"213","author":"Dai","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actbio.2016.08.018_b0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.addr.2015.02.004","article-title":"Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy","volume":"15","author":"Woodsong","year":"2015","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.actbio.2016.08.018_b0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.addr.2016.01.017","article-title":"Nanomedicine in the development of anti-HIV microbicides","volume":"103","author":"das Neves","year":"2016","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.actbio.2016.08.018_b0045","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11095-008-9765-2","article-title":"Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles","volume":"26","author":"Ham","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2016.08.018_b0050","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1089\/aid.2012.0301","article-title":"Polymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatment","volume":"29","author":"Shibata","year":"2013","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.actbio.2016.08.018_b0055","first-page":"2847","article-title":"Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4(+) immune cells","volume":"8","author":"Yang","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2016.08.018_b0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.actbio.2015.02.007","article-title":"Precise engineering of dapivirine-loaded nanoparticles for the development of anti-HIV vaginal microbicides","volume":"18","author":"das Neves","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2016.08.018_b0065","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1021\/acs.molpharmaceut.5b00544","article-title":"Nanoparticle-based ARV drug combinations for synergistic inhibition of cell-free and cell-cell HIV transmission","volume":"12","author":"Jiang","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2016.08.018_b0070","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.actbio.2016.08.018_b0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2016.08.018_b0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2014.12.004","article-title":"Polymer-based nanocarriers for vaginal drug delivery","volume":"92","author":"das Neves","year":"2015","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.actbio.2016.08.018_b0085","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1166\/jbn.2015.1942","article-title":"Thermosensitive gel containing cellulose acetate phthalate-efavirenz combination nanoparticles for prevention of HIV-1 infection","volume":"11","author":"Date","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.actbio.2016.08.018_b0090","doi-asserted-by":"crossref","first-page":"e1005075","DOI":"10.1371\/journal.ppat.1005075","article-title":"Nanoformulations of rilpivirine for topical pericoital and systemic coitus-independent administration efficiently prevent HIV transmission","volume":"11","author":"Kovarova","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.actbio.2016.08.018_b0095","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/jps.23577","article-title":"Vaginal films for drug delivery","volume":"102","author":"Machado","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2016.08.018_b0100","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1007\/s11095-015-1678-2","article-title":"Vaginal microbicide film combinations of two reverse transcriptase inhibitors, EFdA and CSIC, for the prevention of HIV-1 sexual transmission","volume":"32","author":"Zhang","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2016.08.018_b0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2005.11.020","article-title":"The physicodynamic properties of mucoadhesive polymeric films developed as female controlled drug delivery system","volume":"309","author":"Yoo","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2016.08.018_b0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.actbio.2016.08.018_b0115","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ejpb.2007.12.007","article-title":"Performance of an in vitro mucoadhesion testing method for vaginal semisolids: influence of different testing conditions and instrumental parameters","volume":"69","author":"das Neves","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2016.08.018_b0120","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1007\/s11095-013-1287-x","article-title":"Biodistribution and pharmacokinetics of dapivirine-loaded nanoparticles after vaginal delivery in mice","volume":"31","author":"das Neves","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2016.08.018_b0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2012.06.008","article-title":"Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection","volume":"162","author":"Steinbach","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2016.08.018_b0130","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/adhm.201300519","article-title":"Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth","volume":"3","author":"Yang","year":"2014","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.actbio.2016.08.018_b0135","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejpb.2011.06.007","article-title":"PH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission","volume":"79","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2016.08.018_b0140","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ijpharm.2012.07.070","article-title":"Chemico-physical investigation of tenofovir loaded polymeric nanoparticles","volume":"436","author":"Belletti","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2016.08.018_b0145","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2217\/nnm.13.136","article-title":"Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention","volume":"9","author":"Meng","year":"2014","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.actbio.2016.08.018_b0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/aid.2014.0210","article-title":"Anti-HIV drug-combination nanoparticles enhance plasma drug exposure duration as well as triple-drug combination levels in cells within lymph nodes and blood in primates","volume":"31","author":"Freeling","year":"2015","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.actbio.2016.08.018_b0155","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1208\/s12248-010-9177-1","article-title":"Near-infrared investigations of novel anti-HIV tenofovir liposomes","volume":"12","author":"Zidan","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.actbio.2016.08.018_b0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1208\/s12248-013-9546-7","article-title":"Hyaluronidase-sensitive nanoparticle templates for triggered release of HIV\/AIDS microbicide in vitro","volume":"16","author":"Agrahari","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.actbio.2016.08.018_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2007.08.001","article-title":"Nanoparticles for drug delivery: the need for precision in reporting particle size parameters","volume":"69","author":"Gaumet","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2016.08.018_b0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s13346-011-0022-6","article-title":"Development and characterization of a vaginal film containing dapivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), for prevention of HIV-1 sexual transmission","volume":"1","author":"Akil","year":"2011","journal-title":"Drug Delivery Transl. Res."},{"key":"10.1016\/j.actbio.2016.08.018_b0175","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s11095-012-0715-7","article-title":"Vaginal film drug delivery of the pyrimidinedione IQP-0528 for the prevention of HIV infection","volume":"29","author":"Ham","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2016.08.018_b0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2013.11.056","article-title":"Development of a vaginal delivery film containing EFdA, a novel anti-HIV nucleoside reverse transcriptase inhibitor","volume":"461","author":"Zhang","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2016.08.018_b0185","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/mp4007024","article-title":"Increased dapivirine tissue accumulation through vaginal film codelivery of dapivirine and tenofovir","volume":"11","author":"Akil","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2016.08.018_b0190","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s11095-014-1474-4","article-title":"Formulation and characterization of polymeric films containing combinations of antiretrovirals (ARVs) for HIV prevention","volume":"32","author":"Akil","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2016.08.018_b0195","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11095-005-2490-1","article-title":"Development and characterization of bioadhesive vaginal films of sodium polystyrene sulfonate (PSS), a novel contraceptive antimicrobial agent","volume":"22","author":"Garg","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2016.08.018_b0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijpharm.2013.11.033","article-title":"Mechanical strength test for orodispersible and buccal films","volume":"461","author":"Preis","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2016.08.018_b0205","doi-asserted-by":"crossref","first-page":"e48328","DOI":"10.1371\/journal.pone.0048328","article-title":"Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity","volume":"7","author":"Dezzutti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2016.08.018_b0210","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","article-title":"Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review","volume":"39","author":"Sosnik","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.actbio.2016.08.018_b0215","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.biomaterials.2005.12.021","article-title":"Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery","volume":"27","author":"Kim","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.08.018_b0220","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1128\/JVI.00537-11","article-title":"One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates","volume":"85","author":"Denton","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.actbio.2016.08.018_b0225","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1128\/AAC.00456-10","article-title":"In vitro evaluation of viability, integrity and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides","volume":"54","author":"Gali","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actbio.2016.08.018_b0230","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(02)00688-9","article-title":"Preparation and purification of cationic solid lipid nanospheres\u2013effects on particle size, physical stability and cell toxicity","volume":"254","author":"Heydenreich","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2016.08.018_b0235","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1021\/bm900039x","article-title":"Non-cytotoxic silver nanoparticle-polysaccharide nanocomposites with antimicrobial activity","volume":"10","author":"Travan","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2016.08.018_b0240","doi-asserted-by":"crossref","first-page":"15399","DOI":"10.1021\/la101033n","article-title":"Effects of surface chemistry on cytotoxicity, genotoxicity, and the generation of reactive oxygen species induced by ZnO nanoparticles","volume":"26","author":"Yin","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.actbio.2016.08.018_b0245","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0927-7765(93)80021-P","article-title":"Mechanistic study on toxicity of positively charged liposomes containing stearylamine to blood: use of carboxymethyl chitin to reduce toxicity","volume":"1","author":"Nishiya","year":"1993","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.actbio.2016.08.018_b0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0927-7765(94)01158-2","article-title":"Interaction of stearylamine-liposomes with erythrocyte ghosts: analysis of membrane lipid mixing and aqueous contents mixing, and the effect of carboxymethyl chitin on the interaction","volume":"4","author":"Nishiya","year":"1995","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.actbio.2016.08.018_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.qai.0000159671.25950.74","article-title":"In vitro and in vivo: the story of nonoxynol 9","volume":"39","author":"Hillier","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.actbio.2016.08.018_b0260","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/AAC.42.3.612","article-title":"Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), bis(isopropyloxymethylcarbonyl)PMPA","volume":"42","author":"Robbins","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actbio.2016.08.018_b0265","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1128\/AAC.42.6.1484","article-title":"Antiviral activities of 9-R-2-phosphonomethoxypropyl adenine (PMPA) and bis(isopropyloxymethylcarbonyl)PMPA against various drug-resistant human immunodeficiency virus strains","volume":"42","author":"Srinivas","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actbio.2016.08.018_b0270","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/bbrc.1996.0234","article-title":"Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems","volume":"219","author":"Balzarini","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.actbio.2016.08.018_b0275","doi-asserted-by":"crossref","first-page":"e27675","DOI":"10.1371\/journal.pone.0027675","article-title":"Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety","volume":"6","author":"Segarra","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2016.08.018_b0280","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1128\/AAC.49.4.1509-1520.2005","article-title":"Comparative safety evaluation of the candidate vaginal microbicide C31G","volume":"49","author":"Catalone","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actbio.2016.08.018_b0285","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00007435-199903000-00009","article-title":"Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9","volume":"26","author":"Gagn\u00e9","year":"1999","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.actbio.2016.08.018_b0290","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2334-6-90","article-title":"Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission","volume":"6","author":"Cone","year":"2006","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.actbio.2016.08.018_b0295","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3851\/IMP1463","article-title":"Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety","volume":"14","author":"Wilson","year":"2009","journal-title":"Antivir. Ther."},{"issue":"Suppl. 3","key":"10.1016\/j.actbio.2016.08.018_b0300","first-page":"S184","article-title":"Guiding the vaginal microbicide trials with biomarkers of inflammation","volume":"37","author":"Fichorova","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.actbio.2016.08.018_b0305","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1086\/513279","article-title":"A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety","volume":"195","author":"Galen","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actbio.2016.08.018_b0310","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/10731199509117966","article-title":"Mechanistic study on toxicity of positively charged liposomes containing stearylamine to blood","volume":"23","author":"Nishiya","year":"1995","journal-title":"Artif. Cells Blood Substit. Immobil. Biotechnol."},{"key":"10.1016\/j.actbio.2016.08.018_b0315","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1023\/A:1024441702398","article-title":"Physicochemical properties of liposomes affecting apoptosis induced by cationic liposomes in macrophages","volume":"20","author":"Takano","year":"2003","journal-title":"Pharm. Res."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706116304147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706116304147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:50:01Z","timestamp":1761670201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706116304147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":63,"alternative-id":["S1742706116304147"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2016.08.018","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2016.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}